
Vovatrex ET 250mg/250mg Tablet
Marketer
Best Biotech
Salt Composition
Tranexamic Acid (250mg) + Ethamsylate (250mg)
Overview Vovatrex ET 250mg/250mg Tablet
Tranexamic acid and ethinylestradiol 250mg/250mg tablets are prescribed for managing excessive menstrual bleeding. This dual-action medication inhibits clot breakdown, thereby reducing heavy bleeding. It also enhances platelet aggregation, promoting clot formation. The tablets can be taken at any time, with or without food, but consistent daily timing is recommended. Continue treatment as directed by your physician. Follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement. Discontinuing this medication abruptly should only be done under medical supervision. Common side effects include nausea, abdominal discomfort, headache, nasal stuffiness, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea may also occur; increased fluid intake is advised to prevent dehydration. If no menstrual improvement is observed after three consecutive cycles, consult your doctor. Inform your physician of any pre-existing kidney conditions, vaginal bleeding disorders, or pregnancy/breastfeeding status before starting treatment. Disclosure of all other medications currently in use is also necessary. Regular eye examinations may be requested during treatment.
Uses of Vovatrex ET 250mg/250mg Tablet
Menorrhagia
Major Benefits of Vovatrex ET 250mg/250mg Tablet:
Administer Vovatrex ET 250mg/250mg tablets precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
Common Side effects of Vovatrex ET 250mg/250mg Tablet:
- Nausea
- Stomach pain
- Diarrhea
- Headache
- Nasal congestion (stuffy nose)
- Sinus pain
- Sinus inflammation
- Rash
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
How to use Vovatrex ET 250mg/250mg Tablet:
Administer Vovatrex ET 250mg/250mg Tablet as directed by your physician, swallowing the tablet whole. Avoid crushing, chewing, or breaking the tablet. While this medication may be consumed with or without food, consistent daily timing is recommended.
How Vovatrex ET 250mg/250mg Tablet works:
Each Vovatrex ET 250mg/250mg tablet unites Tranexamic Acid and Ethamsylate, two agents that curb excessive bleeding. Tranexamic Acid, an antifibrinolytic, stabilizes blood clots, hindering their dissolution. Ethamsylate, a hemostatic, enhances platelet aggregation—the crucial process of clot formation—and specifically aids in controlling capillary bleeding.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Vovatrex ET 250mg/250mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Pregnancy-related data for Vovatrex ET 250mg/250mg tablets is currently absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Vovatrex ET 250mg/250mg tablets while breastfeeding is absent. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Vovatrex ET 250mg/250mg Tablets.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Vovatrex ET 250mg/250mg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of the 250mg/250mg Vovatrex ET tablet in patients with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Vovatrex ET 250mg/250mg Tablet :
Should you forget a Vovatrex ET 250mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vovatrex ET 250mg/250mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Hematological |
